Cytochrome P450 family 17 subfamily A member 1 mutation causes severe pseudohermaphroditism: A case report

Table 1 The biochemical examinations of the patient

Projects	Results	Reference range
Potassium (mmol/L)	2.26	3.5-5.5
Renin (mIU/L)	< 0.5	2.8-39.9
Aldosterone (ng/dL)	3.69	0-23.6
Angiotension II (pg/ml)	39.1	25-129
FSH (mIU/mL)	38.97	Follicular phase: 3.03-8.08; Ovulatory phase: 2.55-16.69; Luteal phase: 0.9-16.69; Postmenopausal: 26.7-133.4
LH (mIU/mL)	14.49	Follicular phase: 1.8-11.78; Ovulatory phase: 7.59-89.08; Luteal phase: 0.56-14; Postmenopausal: 5.16-61.99
Progesterone (ng/mL)	5.5	Follicular phase: < 0.1-0.3; Luteal phase: 1.20-15.9; Postmenopausal: < 0.1-0.2
Estradiol (pg/mL)	< 10	Follicular phase: 21-251; Luteal phase: 38-649; Postmenopausal: 21-312
Testosterone (ng/dL)	0.18	Male (21-49 yr): 2.4-8.71; Female (21-49 yr): 0.14-0.53
Cortisol (nmol/L)
0 a.m.	83.46	45-135
8 a.m.	170.11	120-660
4 p.m.	106.01	55-200
ACTH (pmol/L)
0 a.m.	8.54	0.4-4.0
8 a.m.	112.85	1.5-14.1
4 p.m.	27.15	0.95-9.5
Dehydroepiandrosterone-S (μg/dL)	17.80	95-510
GH (ng/mL)	0.648	< 8
Urine cortisol for 24 h (μg/24 h)	17.33	19.30-317.50
Urinary potassium 24 h (mmol/24 h)	204.5	25-100
Karyotype	46,XY

FSH: Follicle-stimulating hormone; LH: Luteinizing hormone; ACTH: Aadreno-cortico-tropic-hormone; GH: Growth hormone.